课题基金 / 基金详情

PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS AND

PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS AND
中间终点的临床前评估和
批准号：
3617865
负责人：
MARGIE CLAPPER
金额：
$36.97万
依托单位：
FOX CHASE CANCER CENTER
依托单位国家：
美国
项目类别：
财政年份：
1992
资助国家：
美国
项目状态：
未结题
起止时间：
1992-09-30 至
来源：
https://reporter.nih.gov/project-details/3617865
关键词：
aneuploidy benzopyrenes biomarker carcinogenesis inhibitor chemical carcinogen chemical carcinogenesis chemical related neoplasm /cancer chemoprevention cutaneous papilloma difluoromethylornithine disease /disorder model hyperplasia laboratory mouse nonhuman therapy evaluation preneoplastic state protein glutamine gamma glutamyltransferase skin neoplasms squamous cell carcinoma

项目成果

MARGIE CLAPPER的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINS
TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON CANCER PREVENTIONPREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFF
TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER
TASK ORDER: PREVENTING LUNG CANCER BY TARGETING ACTIVATED STAT3
海外基金